[E4] English Session 4
epilepsy2

[E-014] Efficacy and safety of everolimus in Japanese patients with refractory seizures associated with TSC

^○Masashi Mizuguchi¹, Hiroko Ikeda², Kuriko Kagitani—shimono³, Harumi Yoshinaga⁴, Yasuhiro Suzuki⁵, Makoto Aoki⁶, Chikako Shinpo⁶, Masataka Yonemura⁶, Masaya Kubota⁷ (Department of Developmental Medical Sciences, The University of Tokyo, Tokyo, Japan¹, Department of Pediatrics, Shizuoka Institute of Epilepsy and Neurological Disorders, NHO, Shizuoka, Japan², Department of Pediatrics, Graduate School of Medicine, Osaka University, Osaka, Japan³, Department of Child Neurology, Okayama University Hospital, Okayama, Japan⁴, Department of Pediatric Neurology, Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan⁵, Oncology Development and Medical Affaris, Novartis Pharma K.K., Tokyo, Japan⁶, Division of Neurology, National Center for Child Health and Development, Tokyo, Japan⁷)